An educated citizenry is a vital requisite for our survival as a free people.
Search
Close
  • Support
  • Store
  • About
  • ThinkCivics+
Menu
  • Support
  • Store
  • About
  • ThinkCivics+
Sign In
Subscribe
Support
Home

China’s Vaccine Diplomacy Underscores Global Supply Inequality

With China providing vaccines to developing countries, especially those in Asia, will this move cement its influence in the region?

Jennifer Chance by Jennifer Chance
March 22, 2021
in Editorials, World News
Reading Time: 3 mins read
0
0
HINA-BEIJING-XI JINPING-COVID-19-INSPECTION (CN)

BEIJING, March 2, 2020 -- Chinese President Xi Jinping, also general secretary of the Communist Party of China Central Committee and chairman of the Central Military Commission, talks with experts during his visit to the School of Medicine at Tsinghua University in Beijing, capital of China, March 2, 2020. Xi on Monday inspected the scientific research on novel coronavirus disease COVID-19 as well as the diagnosis and treatment of the disease in his visit to two institutes in Beijing. (photo by Yan Yan/Xinhua via Getty) (Xinhua/Yan Yan via Getty Images)

RelatedPosts

Jaw-Dropping Video Shows Russian Soldiers Wiped Out By ‘Death Ray’ Weapon Fired By Ukraine

Ukraine Intel Chief Says Crimea Will Be Retaken

[lwptoc]

In May 2020, Chinese president Xi Jinping declared that once China develops a vaccine, it will make it a ‘global public good’. This means it will be readily available and affordable for countries that need it. To date, China has two forerunning vaccines – from pharmaceutical companies Sinovac and Sinopharm – that it has already begun distributing, even though trials have shown mixed results. 

 Key Takeaways

  • The United Arab Emirates became the first country to approve Sinopharm’s vaccine on December 10, 2020.
  • On January 4, 2021, Sinopharm received approval for distribution, with an analysis from the Beijing Institute of Biological Products showing that it is 79% effective. 
  • China has secured vaccine deals with countries such as Turkey, the Philippines, and Indonesia before the results of the trials were published.

There is a reason for concern with the two vaccines. Sinopharm has not provided the necessary breakdown of results to show how they reached the 79% effectiveness rate, leaving room for skepticism based on lack of transparency.

The Sinovac vaccine, CoronaVac, also experiences similar concerns. It was sent to countries such as Turkey and Indonesia before being proven effective. Indonesia has since approved the vaccine for emergency use on January 11, with their trials showing that it is 65.3% effective. Brazilian researchers first found the Sinovac to be 78% effective, but in January they modified this number to 50.4%.

How Vaccine Distribution Underscores Global Economic Inequality

Despite the somewhat dubious nature of the vaccines’ effectiveness, China’s move shows that it is willing to share, while other developed nations have prioritized hoarding vaccines and reducing the global supply. 

The City of Sao Paulo Begins the Immunization Against the Coronavirus (COVID-19)-Vaccine
SAO PAULO, BRAZIL – JANUARY 18: A nurse holds a vial of the CoronaVac vaccine at Hospital das Clinicas of the University of Sao Paulo (USP) on January 18, 2021 in Sao Paulo, Brazil. The CoronaVac vaccine was developed by the Chinese laboratory Sinovac in partnership with the Butantan Institute. (Photo by Miguel Schincariol/Getty Images)

As soon as Pfizer and Moderna reported an effectiveness rate of more than 90%, the wealthiest countries on earth began buying up most of their supplies, with several of them already have enough to inoculate their population more than once. On the other hand, developing countries have not been able to secure access to the vaccines. The People’s Vaccine Alliance warns that most of the poorest countries will only be able to vaccinate 10% of their population.

Source: Nature

Even when they can acquire the more effective vaccines, poorer countries may find it difficult to sustain their supply. The Pfizer and Moderna vaccines require storage under very low temperatures (Pfizer at minus 94 degrees Fahrenheit and Moderna at minus 4 degrees Fahrenheit), something that poorer countries may not be able to maintain. In contrast, the Chinese vaccines can be stored at higher temperatures, making it easier for countries to store large amounts of the vaccines. 

Political Intentions of China’s Vaccine Diplomacy

Many experts have claimed that China is using this method as a ‘global charm offensive’, an effort to restore the country’s global reputation, which has plummeted because of the COVID-19 pandemic and other ongoing political issues. The list includes the South China Sea claims, China’s border disputes with India, and their treatment of the Uyghur population. 

By providing vaccines, China picks up the necessary role of coming to the aid of developing countries, especially those in Asia. This move can cement the country’s influence in the region and prevent political tensions, even as other issues such as the South China Sea territorial disputes still occur. 

Why It Matters

Will this diplomatic technique boost China’s international influence beyond that of the United States? The likely scenario is that the US will still hold the upper hand when it comes to international reputation and diplomacy, but it will certainly lead some countries to wonder why, in times of trouble, the United States is not doing more to fulfill its leadership role on the international stage. 

Read: The Congressional Executive Commission on China Calls for Diplomatic Engagement Between the US and the Vatican

In regions such as Southeast Asia, the absence of US support – especially in the past four years, when President Trump’s lack of focus in the area has diminished the country’s influence – will only continue to weaken confidence in the US’s ability to engage, support and protect the region.

Jennifer Chance
Jennifer Chance

Jennifer Chance is a freelance journalist specializing in the coverage of foreign affairs issues. She has been published in the Young Diplomats Society, Journal on World Affairs at UCLA, Southeast Asia Globe and more. She is currently undertaking a Bachelor’s degree in Economics and Politics & International Studies at the University of Melbourne.

Tags: ChinaVaccine
Next Post
President of Iran, Hassan Rouhani

Israel or Iran? Where Does the Biden Administration Stand?

Pope Francis Meets The President Of Haiti Jovenel Moise

Pope Francis Puts Fake News on Blast

ISRAEL-US-POLITICS-DIPLOMACY-DEFENCE

Will the US Protect Gulf Bases with Iron Dome?

Facebook Twitter Rss
  • About
  • Advertise
  • Submissions
  • Contact Us
  • About
  • Advertise
  • Submissions
  • Contact Us
  • Policies & standards
  • Privacy policy
  • Terms and conditions

© 2023 ThinkCivics Media, LLC. All Rights Reserved.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
  • Login
  • Sign Up
  • Cart
  • Home
  • About
  • Store
  • Contact Us
  • Support Us
  • Join
Facebook Twitter Rss
© 2022 ThinkCivics Media. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

OR

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In